Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-09-031266
Filing Date
2009-06-17
Accepted
2009-06-17 16:08:39
Documents
1
Period of Report
2009-06-16

Document Format Files

Seq Description Document Type Size
1 KEF 6/16/09 SELL rrd246238.html 4  
1 KEF 6/16/09 SELL rrd246238.xml 4 16499
  Complete submission text file 0001181431-09-031266.txt   18449
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3400 CENTRAL AVENUE SANTA CLARA CA 95051
Business Address
FALBERG KATHRYN E (Reporting) CIK: 0001206977 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 09896702